Filing Details

Accession Number:
0001062993-24-012192
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-06-07 16:29:51
Reporting Period:
2024-06-05
Accepted Time:
2024-06-07 16:29:51
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1860871 Tevogen Bio Holdings Inc. TVGN Biological Products, (No Disgnostic Substances) (2836) 981597194
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
2011728 H. Ryan Saadi C/O Tevogen Bio Holdings Inc.
15 Independence Blvd, Suite 410
Warren NJ 07059
Chief Executive Officer Yes Yes Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-06-05 2,607 $0.77 118,252,659 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 193,924 Indirect By wife
Footnotes
  1. The price reported in Column 4 represents a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.7635 to $0.7671, inclusive. The reporting person undertakes to provide to Tevogen Bio Holdings Inc., any security holder of Tevogen Bio Holdings Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote.